[Federal Register Volume 64, Number 51 (Wednesday, March 17, 1999)]
[Notices]
[Page 13222]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-6459]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Subcommittee of the Anti-Infective Drugs Advisory Committee; 
Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Subcommittee of the Anti-Infective Drugs 
Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on April 23, 1999, 8:30 
a.m. to 5 p.m.
    Location: Holiday Inn, Kennedy Grand Ballroom, 8777 Georgia Ave., 
Silver Spring, MD.
    Contact Person: Rhonda W. Stover, Center for Drug Evaluation and 
Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-6767, or FDA Advisory Committee 
Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC 
area), code 12530. Please call the Information Line for up-to-date 
information on this meeting.
    Agenda: The subcommittee will discuss issues in the development and 
study of all therapies in children relative to the implementation of 
the agency's new legislative and regulatory efforts to ensure adequate 
labeling and proper pediatric use.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the subcommittee. 
Written submissions may be made to the contact person by April 16, 
1999. Oral presentations from the public will be scheduled between 
approximately 11 a.m. and 12 m. Time allotted for each presentation may 
be limited. Those desiring to make formal oral presentations should 
notify the contact person before April 16, 1999, and submit a brief 
statement of the general nature of the evidence or arguments they wish 
to present, the names and addresses of proposed participants, and an 
indication of the approximate time requested to make their 
presentation.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: March 10, 1999.
 Michael A. Friedman,
 Deputy Commissioner for Operations.
[FR Doc. 99-6459 Filed 3-16-99; 8:45 am]
BILLING CODE 4160-01-F